フランス医薬品産業の再編：企業合併とアライアンス

Hiroatsu Nohara

Post-Print from HAL

Abstract: This paper aims at analyzing the restructuring of the French pharmaceutical industry through Merger and Acquisition (M&A) and alliances. After having described some characteristics of the French pharmaceutical industry – notably, co-existence of big pharmaceutical groups and small family businesses, state policies on the health issues, research collaboration between public labs and pharma companies etc. -, we examine the concrete restructuring process in the three cases. Our purpose is to show how different agents play strategic games associated with their history rather than calculating the economic effectiveness of M&A.

Keywords: Merger; acquisition; family business; state intervention; bio-industry (search for similar items in EconPapers)
Date: 2006-04-21
Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-00485544v1
References: Add references at CitEc
Citations:

Published in the Journal of Health Care and Society, 2006, 17 (1), pp.71-89. ⟨10.4091/iken.17.71⟩

Downloads: (external link)
https://shs.hal.science/halshs-00485544v1/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-00485544

DOI: 10.4091/iken.17.71

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD (hal@ccsd.cnrs.fr).